75 related articles for article (PubMed ID: 15827304)
21. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
22. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
Goldner MG; Knatterud GL; Prout TE
JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
[No Abstract] [Full Text] [Related]
23. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular disease in diabetes and operative risk.
Rossi E
Rays; 1997; 22(4):595-602. PubMed ID: 9550900
[TBL] [Abstract][Full Text] [Related]
25. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland.
Barnett KN; Ogston SA; McMurdo ME; Morris AD; Evans JM
Diabet Med; 2010 Oct; 27(10):1124-9. PubMed ID: 20854379
[TBL] [Abstract][Full Text] [Related]
26. [Type 2 diabetes: increasing therapeutic progress and increasing cardiovascular deaths due to diabetes. So where's the problem?].
Guilmot JL
J Mal Vasc; 2010 Dec; 35(6):345-7. PubMed ID: 21094589
[No Abstract] [Full Text] [Related]
27. Cardiovascular disease and intensive glucose lowering in type 2 diabetes.
Younis N; Soran H; Hassanein M
QJM; 2009 Apr; 102(4):293-6. PubMed ID: 19147659
[No Abstract] [Full Text] [Related]
28. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa.
Kengne AP; Amoah AG; Mbanya JC
Circulation; 2005 Dec; 112(23):3592-601. PubMed ID: 16330701
[TBL] [Abstract][Full Text] [Related]
29. Sulfonylureas and cardiovascular mortality in diabetes: a class effect?
Wascher TC
Circulation; 1998 Apr; 97(14):1427-8. PubMed ID: 9577959
[No Abstract] [Full Text] [Related]
30. [Causes of death in diabetes mellitus].
Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
[No Abstract] [Full Text] [Related]
31. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
Targher G; Bertolini L; Zoppini G; Lippi G; Zenari L
Diabetes Care; 2007 Jun; 30(6):e51; author reply e52. PubMed ID: 17526813
[No Abstract] [Full Text] [Related]
32. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
McCallum RW; Burgess JR; Greenaway TM
Med J Aust; 2009 Jul; 191(1):47-8; author reply 48. PubMed ID: 19580543
[No Abstract] [Full Text] [Related]
33. [Complications after cardiovascular surgery in patients with diabetes].
Jensen TJ
Ugeskr Laeger; 2003 Jan; 165(2):104. PubMed ID: 12553089
[No Abstract] [Full Text] [Related]
34. The global burden of diabetes and its complications: an emerging pandemic.
van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
[TBL] [Abstract][Full Text] [Related]
35. [SGLT2 inhibition in type 2 diabetes. New study data for reducing cardiovascular risk].
MMW Fortschr Med; 2015 Oct; 157(18):86-7. PubMed ID: 26985517
[No Abstract] [Full Text] [Related]
36. End-stage diabetic Nephropathy. Discussion: vascular and visual complications.
Kidney Int Suppl; 1974 Oct; (1):41-6. PubMed ID: 4619136
[No Abstract] [Full Text] [Related]
37. Major cardiovascular disease (CVD) during 1997-1999 and major CVD hospital discharge rates in 1997 among women with diabetes--United States.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):948-54. PubMed ID: 11708592
[TBL] [Abstract][Full Text] [Related]
38. What's in a name?
Gottlieb SH
Diabetes Forecast; 2002 Dec; 55(12):30-1, 33. PubMed ID: 14768616
[No Abstract] [Full Text] [Related]
39. [Insulin resistance increases risk of infarct. Glitazone now approved also for monotherapy].
MMW Fortschr Med; 2003 Sep; 145(38):61. PubMed ID: 14603688
[No Abstract] [Full Text] [Related]
40. Mortality risk in long-standing type 1 diabetes: hope and concern.
Hamman RF
Diabetes; 2010 Dec; 59(12):2997-8. PubMed ID: 21115783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
